Reprise Biomedical, Inc. of Plymouth, MN, a company, filed a Form D amendment with the SEC on 2023-01-25. The offering totals $15.3M, of which $15.3M was reported sold. Industry: Biotechnology.
Showing 25 of 31 people.
| Name | Role | Location |
|---|---|---|
| PHILLIP NALBONE | Director | PLYMOUTH, MN |
| Howard Root | Executive Officer | Plymouth, MN |
| Jeff Ross | Director | Eden Prairie, MN |
| Jake Isenburg | Executive Officer | Plymouth, MN |
| Jake Isenburg | Related Person | Plymouth, MN |
| Carrie Powers | Director | Plymouth, MN |
| Carrie Powers | Executive Officer | Plymouth, MN |
| Carrie Powers | Related Person | Plymouth, MN |
| Ronald Eibensteiner | Director | Plymouth, MN |
| Ronald Eibensteiner | Related Person | Plymouth, MN |
| Phil Nalbone | Director | Plymouth, MN |
| Phil Nalbone | Related Person | Plymouth, MN |
| Howard Root | Director | Plymouth, MN |
| Howard Root | Related Person | Plymouth, MN |
| Tom Kouchoukos | Executive Officer | Plymouth, MN |
| Tom Kouchoukos | Related Person | Plymouth, MN |
| Erwin Kelen | Director | Plymouth, MN |
| Erwin Kelen | Related Person | Plymouth, MN |
| Alan Woldt | Director | Plymouth, MN |
| Alan Woldt | Related Person | Plymouth, MN |
| Jerrod Krueger | Executive Officer | Plymouth, MN |
| Jerrod Krueger | Related Person | Plymouth, MN |
| Jeff Duncan | Executive Officer | Plymouth, MN |
| Jeff Duncan | Related Person | Plymouth, MN |
| Steve Jagodzinski | Executive Officer | Plymouth, MN |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-07-01 | D/A | $10.0M | $9.2M |
| 2026-05-21 | D | $8.0M | $1.4M |
| 2025-07-11 | D | $7.0M | $6.4M |
| 2023-12-13 | D/A | $12.5M | $8.0M |
| 2023-11-02 | D | $10.0M | $4.5M |
| 2023-01-03 | D | $14.8M | $13.0M |
| 2021-03-31 | D/A | $5.0M | $5.0M |
| 2020-11-25 | D | $5.0M | $2.8M |
| 2019-07-12 | D | $12.5M | $12.5M |